Found: 10
Select item for more details and to access through your institution.
MiR‐101a ameliorates AngII‐mediated hypertensive nephropathy by blockade of TGFβ/Smad3 and NF‐κB signalling in a mouse model of hypertension.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 3, p. 246, doi. 10.1111/1440-1681.13042
- By:
- Publication type:
- Article
Update on pathophysiology and preventive strategies of anthracycline‐induced cardiotoxicity.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 3, p. 204, doi. 10.1111/1440-1681.13036
- By:
- Publication type:
- Article
A prospective, randomized trial of intravenous hydroxocobalamin versus noradrenaline or saline for treatment of lipopolysaccharide‐induced hypotension in a swine model.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 3, p. 216, doi. 10.1111/1440-1681.13060
- By:
- Publication type:
- Article
First‐dose effect of the SGLT2 inhibitor ipragliflozin on cardiovascular activity in spontaneously diabetic Torii fatty rats.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 3, p. 266, doi. 10.1111/1440-1681.13053
- By:
- Publication type:
- Article
The role of galectin‐3 in heart failure and cardiovascular disease.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 3, p. 197, doi. 10.1111/1440-1681.13048
- By:
- Publication type:
- Article
Neuregulin‐1 attenuates right ventricular diastolic stiffness in experimental pulmonary hypertension.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 3, p. 255, doi. 10.1111/1440-1681.13043
- By:
- Publication type:
- Article
Supporting preterm cardiovascular function.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 3, p. 274, doi. 10.1111/1440-1681.13044
- By:
- Publication type:
- Article
Silencing of C3G increases cardiomyocyte survival inhibition and apoptosis via regulation of p‐ERK1/2 and Bax.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 3, p. 237, doi. 10.1111/1440-1681.13027
- By:
- Publication type:
- Article
Upregulation of C/EBPβ and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA‐induced hypertrophy.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 3, p. 226, doi. 10.1111/1440-1681.13022
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 3, p. 195, doi. 10.1111/1440-1681.12982
- Publication type:
- Article